サマリー

人体における人工血液の代用は、代用人工血液と呼ばれる。代用血液とは、本物の血液では満たされない身体の生物学的ニーズを満たすために利用される物質である。人工血液を作るには、炭素とフッ素からなる一連の化学物質が使われる。これらの分子は、血漿の50倍の酸素を体内に溶かし込むことができる。内部では、分子は血液と同様の働きをし、体内のさまざまな部位、臓器、組織に酸素を供給する。患者は大惨事の怪我や病気の結果、大量の血液を失い、毎年何千人もの患者が死亡している。また、新鮮な血液の寿命は42時間である。このような障害から、患者の当面の血液供給ニーズを満たし、延命するためには、人工血液による代用が必要となる。

世界の代用合成血液と血液製品市場は、COVID-19とロシア・ウクライナ戦争の二重の影響を受けた2022年の100万米ドルに比べ、2023年には％のプラス成長で100万米ドルに達すると予想される。川下産業からの需要の増加を背景に、合成血液代替品と血液製品産業は2029年に百万米ドルに達すると評価されている。2023年から2029年までのCAGRは％である。

当社の調査によると、医療機器の世界市場は2023年に6,030億米ドルと推定され、今後6年間のCAGRは5％で成長する。世界の医療支出は世界GDPの10%を占め、高齢化による健康ニーズの増加、慢性疾患や感染症の流行、新興市場の拡大により、近年増加し続けています。医療機器市場は、ヘルスケア産業において重要な役割を果たしている。この市場を牽引しているのは、世界的な高度医療サービスに対する需要の高まり、医療技術の進歩、高齢者人口の増加、医療費の増加、病気の早期診断・治療に対する意識の高まりなど、いくつかの要因である。

レポートの対象
本レポートは、2018年から2029年までの世界の合成血液代替品および血液製剤市場の概観を紹介し、読者が世界の合成血液代替品および血液製剤市場を多角的に包括的に理解することを目的としています。2018年から2029年までの地域別売上高、収益、2018年から2023年までのメーカーの売上高、価格、収益、粗利益率などの項目を分析しています。さらに、2018年から2029年までの各地域における製品タイプおよび用途の売上高と収益も取り上げています。

レポートに掲載されているメーカー、タイプ、アプリケーション、地域
企業別
KaloCyte Inc.
NuvOx Pharma LLC
ノースフィールド・ラボラトリーズ
デントリテック社
ヘモバイオテック社
デキストロサン社
バクスターインターナショナル
FluorO2セラピューティクス
アルファ・セラピューティック社
ヘモグロビン酸素セラピューティクスLLC
スフェリテック社
サンガート社
バイオピュア
PHORNANO Holding GmbH
タイプ別セグメント
ヒト血液
動物血液
微生物
合成ポリマー
幹細胞
その他
用途別セグメント
病院とクリニック
血液銀行
その他
地域別セグメント
米国およびカナダ
米国
カナダ
中国
アジア（中国を除く）
日本
韓国
中国 台湾
東南アジア
インド
ヨーロッパ
ドイツ
フランス
英国
イタリア
ロシア
ラテンアメリカ、中東、アフリカ
ブラジル
メキシコ
トルコ
イスラエル
GCC諸国

章の概要
第1章：製品の定義、種類、用途の紹介
第2章：2018年から2029年までの地域別収益および販売量分析
第3章：メーカーの売上高、収益および価格分析、メーカーの合成血液代替品および血液製品の工場分布、合成血液代替品および血液製品の商業日、提供される製品タイプ、M&Aおよび拡大活動を含む。
第4章：2018年から2029年までの世界のタイプ別製品売上高、収益、価格分析
第5章：2018年から2029年までの世界的な用途別製品売上高、収益および価格分析
第6章：米国・カナダにおける2018年から2029年までのタイプ別・用途別製品売上高、収益分析2018年から2029年までの米国＆カナダにおける各国別製品売上高、収益分析
第7章：ヨーロッパにおける2018年から2029年までの製品の販売、タイプ別および用途別収益分析。2018年から2029年までの欧州各国の製品売上高、収益分析
第8章：2018年から2029年までの中国における製品の売上高、タイプ別および用途別の収益分析。2018年から2029年までの中国の製品売上高、収益分析
第9章：2018年から2029年までのアジア（中国を除く）における製品売上高、タイプ別および用途別収益分析。2018年から2029年までのアジア（中国を除く）各国の製品売上高、収益分析
第10章：2018年から2029年までの中東、アフリカ、ラテンアメリカにおける製品の販売、タイプ別および用途別収益分析。2018年から2029年までの中東、アフリカ、ラテンアメリカの各国における製品売上高、収益分析。
第11章：メーカーの概要、企業の基本情報、主要事業、代用合成血液と血液製品の紹介などをカバー。2018年から2023年までの各社の合成血液代替品および血液製品の売上高、収益、価格およびグロスマージン
第12章：原材料、製造コストのような産業チェーン分析。市場チャネル、流通業者、顧客分析
第13章：市場機会と課題分析
第14章：QYResearchによる代用合成血液と血液製品の結論
第15章 QYResearchが採用した方法論とデータソース

ページTOPに戻る

目次

1 Study Coverage
1.1 Synthetic Blood Substitutes and Blood Product Product Introduction
1.2 Market by Type
1.2.1 Global Synthetic Blood Substitutes and Blood Product Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Human Blood
1.2.3 Animal Blood
1.2.4 Microorganisms
1.2.5 Synthetic Polymers
1.2.6 Stem Cells
1.2.7 Others
1.3 Market by Application
1.3.1 Global Synthetic Blood Substitutes and Blood Product Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospitals and Clinics
1.3.3 Blood Banks
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Synthetic Blood Substitutes and Blood Product Sales Estimates and Forecasts 2018-2029
2.2 Global Synthetic Blood Substitutes and Blood Product Revenue by Region
2.2.1 Global Synthetic Blood Substitutes and Blood Product Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Synthetic Blood Substitutes and Blood Product Revenue by Region (2018-2023)
2.2.3 Global Synthetic Blood Substitutes and Blood Product Revenue by Region (2024-2029)
2.2.4 Global Synthetic Blood Substitutes and Blood Product Revenue Market Share by Region (2018-2029)
2.3 Global Synthetic Blood Substitutes and Blood Product Sales Estimates and Forecasts 2018-2029
2.4 Global Synthetic Blood Substitutes and Blood Product Sales by Region
2.4.1 Global Synthetic Blood Substitutes and Blood Product Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Synthetic Blood Substitutes and Blood Product Sales by Region (2018-2023)
2.4.3 Global Synthetic Blood Substitutes and Blood Product Sales by Region (2024-2029)
2.4.4 Global Synthetic Blood Substitutes and Blood Product Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Synthetic Blood Substitutes and Blood Product Sales by Manufacturers
3.1.1 Global Synthetic Blood Substitutes and Blood Product Sales by Manufacturers (2018-2023)
3.1.2 Global Synthetic Blood Substitutes and Blood Product Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Synthetic Blood Substitutes and Blood Product in 2022
3.2 Global Synthetic Blood Substitutes and Blood Product Revenue by Manufacturers
3.2.1 Global Synthetic Blood Substitutes and Blood Product Revenue by Manufacturers (2018-2023)
3.2.2 Global Synthetic Blood Substitutes and Blood Product Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Synthetic Blood Substitutes and Blood Product Revenue in 2022
3.3 Global Key Players of Synthetic Blood Substitutes and Blood Product, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Synthetic Blood Substitutes and Blood Product Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Synthetic Blood Substitutes and Blood Product Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Synthetic Blood Substitutes and Blood Product, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Synthetic Blood Substitutes and Blood Product, Product Offered and Application
3.8 Global Key Manufacturers of Synthetic Blood Substitutes and Blood Product, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Synthetic Blood Substitutes and Blood Product Sales by Type
4.1.1 Global Synthetic Blood Substitutes and Blood Product Historical Sales by Type (2018-2023)
4.1.2 Global Synthetic Blood Substitutes and Blood Product Forecasted Sales by Type (2024-2029)
4.1.3 Global Synthetic Blood Substitutes and Blood Product Sales Market Share by Type (2018-2029)
4.2 Global Synthetic Blood Substitutes and Blood Product Revenue by Type
4.2.1 Global Synthetic Blood Substitutes and Blood Product Historical Revenue by Type (2018-2023)
4.2.2 Global Synthetic Blood Substitutes and Blood Product Forecasted Revenue by Type (2024-2029)
4.2.3 Global Synthetic Blood Substitutes and Blood Product Revenue Market Share by Type (2018-2029)
4.3 Global Synthetic Blood Substitutes and Blood Product Price by Type
4.3.1 Global Synthetic Blood Substitutes and Blood Product Price by Type (2018-2023)
4.3.2 Global Synthetic Blood Substitutes and Blood Product Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Synthetic Blood Substitutes and Blood Product Sales by Application
5.1.1 Global Synthetic Blood Substitutes and Blood Product Historical Sales by Application (2018-2023)
5.1.2 Global Synthetic Blood Substitutes and Blood Product Forecasted Sales by Application (2024-2029)
5.1.3 Global Synthetic Blood Substitutes and Blood Product Sales Market Share by Application (2018-2029)
5.2 Global Synthetic Blood Substitutes and Blood Product Revenue by Application
5.2.1 Global Synthetic Blood Substitutes and Blood Product Historical Revenue by Application (2018-2023)
5.2.2 Global Synthetic Blood Substitutes and Blood Product Forecasted Revenue by Application (2024-2029)
5.2.3 Global Synthetic Blood Substitutes and Blood Product Revenue Market Share by Application (2018-2029)
5.3 Global Synthetic Blood Substitutes and Blood Product Price by Application
5.3.1 Global Synthetic Blood Substitutes and Blood Product Price by Application (2018-2023)
5.3.2 Global Synthetic Blood Substitutes and Blood Product Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Synthetic Blood Substitutes and Blood Product Market Size by Type
6.1.1 US & Canada Synthetic Blood Substitutes and Blood Product Sales by Type (2018-2029)
6.1.2 US & Canada Synthetic Blood Substitutes and Blood Product Revenue by Type (2018-2029)
6.2 US & Canada Synthetic Blood Substitutes and Blood Product Market Size by Application
6.2.1 US & Canada Synthetic Blood Substitutes and Blood Product Sales by Application (2018-2029)
6.2.2 US & Canada Synthetic Blood Substitutes and Blood Product Revenue by Application (2018-2029)
6.3 US & Canada Synthetic Blood Substitutes and Blood Product Market Size by Country
6.3.1 US & Canada Synthetic Blood Substitutes and Blood Product Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Synthetic Blood Substitutes and Blood Product Sales by Country (2018-2029)
6.3.3 US & Canada Synthetic Blood Substitutes and Blood Product Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Synthetic Blood Substitutes and Blood Product Market Size by Type
7.1.1 Europe Synthetic Blood Substitutes and Blood Product Sales by Type (2018-2029)
7.1.2 Europe Synthetic Blood Substitutes and Blood Product Revenue by Type (2018-2029)
7.2 Europe Synthetic Blood Substitutes and Blood Product Market Size by Application
7.2.1 Europe Synthetic Blood Substitutes and Blood Product Sales by Application (2018-2029)
7.2.2 Europe Synthetic Blood Substitutes and Blood Product Revenue by Application (2018-2029)
7.3 Europe Synthetic Blood Substitutes and Blood Product Market Size by Country
7.3.1 Europe Synthetic Blood Substitutes and Blood Product Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Synthetic Blood Substitutes and Blood Product Sales by Country (2018-2029)
7.3.3 Europe Synthetic Blood Substitutes and Blood Product Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Synthetic Blood Substitutes and Blood Product Market Size
8.1.1 China Synthetic Blood Substitutes and Blood Product Sales (2018-2029)
8.1.2 China Synthetic Blood Substitutes and Blood Product Revenue (2018-2029)
8.2 China Synthetic Blood Substitutes and Blood Product Market Size by Application
8.2.1 China Synthetic Blood Substitutes and Blood Product Sales by Application (2018-2029)
8.2.2 China Synthetic Blood Substitutes and Blood Product Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Synthetic Blood Substitutes and Blood Product Market Size by Type
9.1.1 Asia Synthetic Blood Substitutes and Blood Product Sales by Type (2018-2029)
9.1.2 Asia Synthetic Blood Substitutes and Blood Product Revenue by Type (2018-2029)
9.2 Asia Synthetic Blood Substitutes and Blood Product Market Size by Application
9.2.1 Asia Synthetic Blood Substitutes and Blood Product Sales by Application (2018-2029)
9.2.2 Asia Synthetic Blood Substitutes and Blood Product Revenue by Application (2018-2029)
9.3 Asia Synthetic Blood Substitutes and Blood Product Sales by Region
9.3.1 Asia Synthetic Blood Substitutes and Blood Product Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Synthetic Blood Substitutes and Blood Product Revenue by Region (2018-2029)
9.3.3 Asia Synthetic Blood Substitutes and Blood Product Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Synthetic Blood Substitutes and Blood Product Market Size by Type
10.1.1 Middle East, Africa and Latin America Synthetic Blood Substitutes and Blood Product Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Synthetic Blood Substitutes and Blood Product Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Synthetic Blood Substitutes and Blood Product Market Size by Application
10.2.1 Middle East, Africa and Latin America Synthetic Blood Substitutes and Blood Product Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Synthetic Blood Substitutes and Blood Product Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Synthetic Blood Substitutes and Blood Product Sales by Country
10.3.1 Middle East, Africa and Latin America Synthetic Blood Substitutes and Blood Product Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Synthetic Blood Substitutes and Blood Product Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Synthetic Blood Substitutes and Blood Product Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Aurum Biosciences Ltd
11.1.1 Aurum Biosciences Ltd Company Information
11.1.2 Aurum Biosciences Ltd Overview
11.1.3 Aurum Biosciences Ltd Synthetic Blood Substitutes and Blood Product Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Aurum Biosciences Ltd Synthetic Blood Substitutes and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Aurum Biosciences Ltd Recent Developments
11.2 Hemarina SA
11.2.1 Hemarina SA Company Information
11.2.2 Hemarina SA Overview
11.2.3 Hemarina SA Synthetic Blood Substitutes and Blood Product Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Hemarina SA Synthetic Blood Substitutes and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Hemarina SA Recent Developments
11.3 KaloCyte Inc.
11.3.1 KaloCyte Inc. Company Information
11.3.2 KaloCyte Inc. Overview
11.3.3 KaloCyte Inc. Synthetic Blood Substitutes and Blood Product Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 KaloCyte Inc. Synthetic Blood Substitutes and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 KaloCyte Inc. Recent Developments
11.4 NuvOx Pharma LLC
11.4.1 NuvOx Pharma LLC Company Information
11.4.2 NuvOx Pharma LLC Overview
11.4.3 NuvOx Pharma LLC Synthetic Blood Substitutes and Blood Product Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 NuvOx Pharma LLC Synthetic Blood Substitutes and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 NuvOx Pharma LLC Recent Developments
11.5 Northfield Laboratories
11.5.1 Northfield Laboratories Company Information
11.5.2 Northfield Laboratories Overview
11.5.3 Northfield Laboratories Synthetic Blood Substitutes and Blood Product Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Northfield Laboratories Synthetic Blood Substitutes and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Northfield Laboratories Recent Developments
11.6 Dentritech, Inc.
11.6.1 Dentritech, Inc. Company Information
11.6.2 Dentritech, Inc. Overview
11.6.3 Dentritech, Inc. Synthetic Blood Substitutes and Blood Product Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Dentritech, Inc. Synthetic Blood Substitutes and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Dentritech, Inc. Recent Developments
11.7 HemoBioTech, Inc.
11.7.1 HemoBioTech, Inc. Company Information
11.7.2 HemoBioTech, Inc. Overview
11.7.3 HemoBioTech, Inc. Synthetic Blood Substitutes and Blood Product Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 HemoBioTech, Inc. Synthetic Blood Substitutes and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 HemoBioTech, Inc. Recent Developments
11.8 Dextro-Sang Corp.
11.8.1 Dextro-Sang Corp. Company Information
11.8.2 Dextro-Sang Corp. Overview
11.8.3 Dextro-Sang Corp. Synthetic Blood Substitutes and Blood Product Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 Dextro-Sang Corp. Synthetic Blood Substitutes and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Dextro-Sang Corp. Recent Developments
11.9 Baxter International
11.9.1 Baxter International Company Information
11.9.2 Baxter International Overview
11.9.3 Baxter International Synthetic Blood Substitutes and Blood Product Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 Baxter International Synthetic Blood Substitutes and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Baxter International Recent Developments
11.10 FluorO2 Therapeutics
11.10.1 FluorO2 Therapeutics Company Information
11.10.2 FluorO2 Therapeutics Overview
11.10.3 FluorO2 Therapeutics Synthetic Blood Substitutes and Blood Product Sales, Price, Revenue and Gross Margin (2018-2023)
11.10.4 FluorO2 Therapeutics Synthetic Blood Substitutes and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 FluorO2 Therapeutics Recent Developments
11.11 Alpha Therapeutic Corp.
11.11.1 Alpha Therapeutic Corp. Company Information
11.11.2 Alpha Therapeutic Corp. Overview
11.11.3 Alpha Therapeutic Corp. Synthetic Blood Substitutes and Blood Product Sales, Price, Revenue and Gross Margin (2018-2023)
11.11.4 Alpha Therapeutic Corp. Synthetic Blood Substitutes and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Alpha Therapeutic Corp. Recent Developments
11.12 Hemoglobin Oxygen Therapeutics LLC
11.12.1 Hemoglobin Oxygen Therapeutics LLC Company Information
11.12.2 Hemoglobin Oxygen Therapeutics LLC Overview
11.12.3 Hemoglobin Oxygen Therapeutics LLC Synthetic Blood Substitutes and Blood Product Sales, Price, Revenue and Gross Margin (2018-2023)
11.12.4 Hemoglobin Oxygen Therapeutics LLC Synthetic Blood Substitutes and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Hemoglobin Oxygen Therapeutics LLC Recent Developments
11.13 SpheriTech Ltd
11.13.1 SpheriTech Ltd Company Information
11.13.2 SpheriTech Ltd Overview
11.13.3 SpheriTech Ltd Synthetic Blood Substitutes and Blood Product Sales, Price, Revenue and Gross Margin (2018-2023)
11.13.4 SpheriTech Ltd Synthetic Blood Substitutes and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 SpheriTech Ltd Recent Developments
11.14 Sangart, Inc.
11.14.1 Sangart, Inc. Company Information
11.14.2 Sangart, Inc. Overview
11.14.3 Sangart, Inc. Synthetic Blood Substitutes and Blood Product Sales, Price, Revenue and Gross Margin (2018-2023)
11.14.4 Sangart, Inc. Synthetic Blood Substitutes and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Sangart, Inc. Recent Developments
11.15 BioPure
11.15.1 BioPure Company Information
11.15.2 BioPure Overview
11.15.3 BioPure Synthetic Blood Substitutes and Blood Product Sales, Price, Revenue and Gross Margin (2018-2023)
11.15.4 BioPure Synthetic Blood Substitutes and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 BioPure Recent Developments
11.16 PHORNANO Holding GmbH
11.16.1 PHORNANO Holding GmbH Company Information
11.16.2 PHORNANO Holding GmbH Overview
11.16.3 PHORNANO Holding GmbH Synthetic Blood Substitutes and Blood Product Sales, Price, Revenue and Gross Margin (2018-2023)
11.16.4 PHORNANO Holding GmbH Synthetic Blood Substitutes and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 PHORNANO Holding GmbH Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Synthetic Blood Substitutes and Blood Product Industry Chain Analysis
12.2 Synthetic Blood Substitutes and Blood Product Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Synthetic Blood Substitutes and Blood Product Production Mode & Process
12.4 Synthetic Blood Substitutes and Blood Product Sales and Marketing
12.4.1 Synthetic Blood Substitutes and Blood Product Sales Channels
12.4.2 Synthetic Blood Substitutes and Blood Product Distributors
12.5 Synthetic Blood Substitutes and Blood Product Customers
13 Market Dynamics
13.1 Synthetic Blood Substitutes and Blood Product Industry Trends
13.2 Synthetic Blood Substitutes and Blood Product Market Drivers
13.3 Synthetic Blood Substitutes and Blood Product Market Challenges
13.4 Synthetic Blood Substitutes and Blood Product Market Restraints
14 Key Findings in The Global Synthetic Blood Substitutes and Blood Product Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer